Skip to content

Clinical trials

Completed Phase 2/3 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Singapore Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20091
20101
20111
20124
20133
20141
20152
20164
20172
20184
20191
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
National University Hospital, Singapore3
ASLAN Pharmaceuticals2
AbbVie2
AstraZeneca2
Novartis Pharmaceuticals2
Alpha Biopharma (Jiangsu) Co., Ltd.1
Anthera Pharmaceuticals1
Boehringer Ingelheim1
Changi General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-192
Carcinoma, Non-Small-Cell Lung2
Colitis, Ulcerative2
Hemophilia A2
Lung Neoplasms2
Neoplasms2
Stomach Neoplasms2
Attention Deficit Disorder with Hyperactivity1
Bile Duct Neoplasms1
Biliary Tract Neoplasms1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.